A phase III trial comparing adjuvant versus salvage radiotherapy for high risk patients post radical prostatectomy

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

About half of all patients Treated with an operation to remove their prostate cancer have a high chance of the cancer coming back. Giving immediate radiotherapy to all patients will improve cure rates but does not benefit all men and can cause significant side effects. This study explores whether it is safe to wait and only give radiotherapy when there is a rising PSA after surgery indicating active cancer. A total of 470 men from Australasia will enter this study comparing the two approaches.

Funded Activity Details

Start Date: 01-01-2009

End Date: 01-01-2016

Funding Scheme: Project Grants

Funding Amount: $819,138.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Radiotherapy And Nuclear Medicine

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

Prostate Cancer | Prostate cancer | Quality of Life | Quality of life | Radical Prostatectomy | Radiotherapy | Randomised controlled trial | Toxicity